देश: आर्मेनिया
भाषा: अंग्रेज़ी
स्रोत: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
fenticonazole (fenticonazole nitrate)
Recordati Industria Chimica e Farmaceutica S.p.A.
G01AC12, D01AF12
fenticonazole (fenticonazole nitrate)
20mg/g
cream for vaginal and external use
30g aluminium tube, 78g aluminium tube and dispenser
Prescription
Registered
2016-04-02
MINISTRY OF HEALTI.I OF THE RUSSIAN TEDERATION PATTENT INFORMATION LEAFI"ET cln the drug for nedicai use LOMEXIN@ i Registration number: Trade nams of the drug: Lomexin INN: Fenticonazole Chemical n&me! 1-[(2RS)-2-(2,4-dic]rlorophenyl)-2-[[4-(phenylsulfanyl) berizyl] oxyl ethyll-1H- inridazole nitrate Dosnge form: cream for vaginal and external use Composition per 100 g of the cream Active subslance'. Fentieonazole nitate 2.00 g Excipients: Water 60.50 g Glyceryl monostearate .....................,...... 3, 00 g Disodium edetate 0"50 g Fatty acids and macrogol ether 15.00 g Hydrogenated lanolin 1.00 g Ahnoncloil ............. 10.00 g Propylene glycol 5.00 g Cetyl alcohol .............. ..........3.00 g Description White honrogeueous crearn. Fharmacother:l peutic group Anti{ungal agerit /;P ," q ",{/''r{eyy irgr rr i (A.*OJ./f ATC code: G01AFl2. D01AC12 Fh nrmacological properf ies Pharmacodynamics Lome'rin is an antiftlngal cirug of broad spectrum of action for externa] and topical admi*istration. Fenticonazole (active substance of Lomexin) is a synthetic derivative of imidazole (its racernic ntixture in the fo|m of nifrate sait of fbnticonazole), it provides local fungicidal and fiurgistatic action' [t also has an antibacteriai effect, The rnechanism of action is inhibirion of t]re synthesis of etgosterol which regulates the Permeability of cell niembrane of fungi, It is active against dcrrrratophyles'fr|'allaryhytorz sp2t., MicrosporLtnz spp.. Epidet'ntoplzyton spp.. pit.vrtssporr{il.t ttrbicttlare and P rsvole, yeast lungi Cctndida Eryr. (includ ing Canclicla albiccuts')ar-icl Gram-positive bacteria (staphllococcus aureus, streptor:oc€t,ts spp.), as wellas against Tiichomoncts vaginali,s. Unlike other knou"rr azole compounds (in particular, econaz'ole, miconazole. ancl ketoconazoie), lbnticonazole inhibits biosynthesi s of Cctnc{idct.spp. proteases in concentrations less tSan tlrc nrinimltnt inhibitory concentration - from 0.25 to 16 ptg linl, Tliis action is independe't of tlre mtifiingalactivity and due to पूरा दस्तावेज़ पढ़ें
RECORDATI Industria Chimica e Farmaceutica S.p.A. 1 Summary of Product Characteristic Dermatological Fenticonazole – January 2015 SAMMARY OF PRODUCTS CHARACTERISTICS DERMATOLOGICAL FENTICONAZOLE 1. TRADE NAME OF THE MEDICINAL PRODUCT LOMEXIN 2% CREAM LOMEXIN 2% GEL LOMEXIN 2% CUTANEOUS SOLUTION, LOMEXIN 2% CUTANEOUS SPRAY, SOLUTION LOMEXIN 2% CUTANEOUS POWDER LOMEXIN 2% SHAMPOO LOMEXIN 2% CUTANEOUS FOAM 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _ _ _2% CREAM: _ 100 g of cream contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _2% GEL: _ 100 g of gel contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _2% CUTANEOUS SOLUTION: _ 100 g of solution contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _ _ _2% CUTANEOUS SPRAY, SOLUTION: _ 100 g of solution contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _2% CUTANEOUS POWDER: _ 100 g of powder contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _2% SHAMPOO: _ 100 g of solution contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) _2% CUTANEOUS FOAM: _ RECORDATI Industria Chimica e Farmaceutica S.p.A. 2 Summary of Product Characteristic Dermatological Fenticonazole – January 2015 100 g of solution contain: _Active ingredient: _ Fenticonazole nitrate 2 g (equal to 1.757 g Fenticonazole) For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Cream Gel Cutaneous solution Cutaneous spray, solution Cutaneous powder Shampoo Cutaneous foam 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Dermatomycoses from dermatophytes (_Tricophyton, Microsporum, Epidermophyton_) in different locations: tinea capitis, tinea corporis, tinea cruris, tinea pedis (athletes foot), tinea manuum, tinea faciei, tinea barbae, tinea unguium. - Skin candidiasis (intertrigo, perleche, facial candidiasis, “diaper” candidiasis, perineal and scrotal ca पूरा दस्तावेज़ पढ़ें